36 /100
MEDIUM RISK
Score updated Jul 14, 2026

CMCAW — Piermont Valley Acquisition Corp Dilution Risk Tracker

Track CMCAW dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track CMCAW — Get alerts when the score changes →

As of July 14, 2026, Piermont Valley Acquisition Corp (CMCAW) has a DilutionWatch DilutionScore of 36/100, rated MEDIUM dilution risk. Piermont Valley Acquisition Corp has 5.95M shares outstanding. Key dilution vectors include approximately 46 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
0
📊 Float Risk
92
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for CMCAW.
🔔 Track CMCAW — Get forecast alerts →

💹 Market Data

Market CapN/A
Shares Outstanding5.95M
Float204.4K
Cash$2.46M
Debt$710.4K
Short InterestN/A

🏛 Institutional Holdings

Institutional data not yet available.

📉 Short Interest

Short Interest395
Days to Cover1.0
% of Float0.2%
FINRA data as of Mar 31, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Mar 31, 2026
xbrl XBRL CONVERTIBLE Mar 31, 2024
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for CMCAW Shareholders

Piermont Valley Acquisition Corp (CMCAW) has a DilutionScore of 36/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 14, 2026.

DilutionWatch's EDGAR monitoring for CMCAW shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for CMCAW in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for CMCAW alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track CMCAW Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking CMCAW — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for CMCAW
📊 CMCAW FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 CMCAW Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.